F16, a fraction from Eurycoma longifolia Jack extract, induces apoptosis via a caspase-9-independent manner in MCF-7 cells

Anticancer Research

Volumn 27, Issue 5 A, 2007, Pages 3425-3430

  Thiam, Tsui Tee ^a   Yew, Hoong Cheah ^b   Hawariah, Lope Pihie Azimahtol ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Antiproliferative effect; Apoptosis; Eurycoma longifolia; MCF 7; PARP

Indexed keywords

CASPASE 7; CASPASE 9; EURYCOMA LONGIFOLIA EXTRACT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROCASPASE 9; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG SYNTHESIS; EURYCOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; WESTERN BLOTTING;

APOPTOSIS; BREAST NEOPLASMS; CASPASE 7; CASPASE 9; CELL LINE, TUMOR; ENZYME ACTIVATION; EURYCOMA; HUMANS; PLANT EXTRACTS; POLY(ADP-RIBOSE) POLYMERASES;

EID: 35348957300     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF and Koropatnick DJ: A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr 134: 1529-1535, 2004.
2. Kiechle FL and Zhang X: Apoptosis: biochemical aspects and clinical implications. Clinica Chimica Acta 326: 27-45, 2002.
3. Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000.
4. Bold RJ, Termuhlen PM and McConkey DJ: Apoptosis, cancer and cancer therapy. Surg Oncol 6: 133-142, 1997.
5. Hickman JA: Apoptosis, induced by anticancer drugs. Cancer Metastasis Rev 11: 121-139, 1992.
6. Sen S and D'Incalci M: Apoptosis: biochemical events and relevance to cancer chemotherapy. FEBS Lett 307: 122-127, 1992.
7. Barry MA, Behnke CA and Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
8. Bode AM and Dong Z: Targeting signal transduction pathways by chemopreventive agents. Mutation Research 555: 33-51, 2004.
9. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
10. Fadeel B, Orrenius S and Zhivotovsky B: Apoptosis in human disease: A new skin for the old ceremony. Biochem Biophys Res Comm 266: 699-717, 1999.
11. Thompson CB: Apoptosis in pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
12. Slee EA, O'Connor DJ and Lu X: To die or not to die: how does p53 decide? Oncogene 23: 2809-2818, 2004.
13. Green DR: Apoptotic pathways: the roads to ruin. Cell 94: 695-698, 1998.
14. Salvesen GS and Dixit VM: Caspases: intracellular signalling by proteolysis. Cell 91: 443-446, 1997.
15. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997.
16. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91: 479-489, 1997.
17. D'Amours D, Sallmann FR, Dixit VM and Poirier GG: Gain-of-function of poly(ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J Cell Sci 114: 3771-3778, 2001.
18. Tee TT and Azimahtol Hawariah LP: Induction of apoptosis by Eurycoma longifolia Jack extracts. Anticancer Res 25: 2205-2214, 2005.
19. Kottke TJ, Blajeski AL, Meng XW, Svingen PA, Ruchaud S, Mesner JPW, Boerner SA, Samejima K, Henriquez NV, Chilcote TJ, Lord J, Salmon M, Earnshaw WC and Kaufmann SH: Lack of correlation between caspase activation and caspase activity assays in paclitaxel-treated MCF-7 breast cancer cells. J Biol Chem 277: 804-815, 2002.
20. Marcelli M, Cunningham GR, Walkup M, He Z, Sturgis L, Kagan C, Mannucci R, Nicoletti I, Teng BB and Denner L: Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: Overexpression of caspase-7 as a new gene therapy strategy for prostate cancer. Cancer Res 59: 382-390, 1999.
21. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG: Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985, 1993.
22. Alexandre S, Rast C, Nguyen-Ba G, Poirier GG and Vasseur P: PARP degradation in apoptotic Syrian hamster embryo (SHE) cells compared to HL60 cell line. Biochimie 82: 1115-1122, 2000.
23. Blagosklonny MV, Iglesias A, Zhan Z and Fojo T: Like p53, the proliferation-associated protein p120 accumulates in human cancer cells following exposure to anticancer drugs. Biochem Biophys Res Commun 244: 368-373, 1998.
24. Fritsche M, Haessler C and Brandner G: Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8: 307-318, 1993.
25. L, without alteration of p53 protein levels. Clin Cancer Res 5: 2971-2977, 1999.
26. Lanni JS, Lowe SW, Licitra EJ, Liu JO and Jacks T: p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc Natl Acad Sci USA 94: 9679-9683, 1997.
27. Dixon SC, Soriano BJ, Lush RM, Borner MM and Figg WD: Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target. Ann Pharmacother 31: 76-82, 1997.
28. Adams JM: Ways of dying: multiple pathways to apoptosis. Genes Dev 17: 2481-2495, 2003.
29. Shi Y: Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9: 459-470, 2002.
30. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM and Mak TW: Differential requirement for caspase-9 in apoptotic pathways in vivo. Cell 94: 339-352, 1998.
31. Honarpour N, Tabuchi K, Stark JM, Hammer RE, Sudhof TC, Parada LF, Wang X, Richardson JA and Herz J: Embryonic neuronal death due to neurotrophin and neurotransmitter deprivation occurs independent of Apaf-1. Neuroscience 106: 263-274, 2001.
32. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K and Tomaselli KJ: Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419: 634-637, 2002.
33. Ferguson HA, Marietta PM and Berg CLVD: UV-induced apoptosis is mediated independent of caspase-9 in MCF-7 cells. Biol Chem 278: 45793-45800, 2003.
34. Ofir R, Seidman R, Rabinski T, Krup M, Yavelsky V, Weinstein Y and Wolfson M: Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent. Cell Death Differ 9: 636-642, 2002.
35. Janicke RU, Ng P, Sprengart ML and Porter AG: Caspase-3 is required for α-Fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem 273: 15540-15545, 1998.
36. Yang XH, Sladek TL, Liu X, Butler BR, Froelich CJ and Thor AD: Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res 61: 348-354, 2001.
37. Kugawa F, Matsumoto K and Aoki M: Apoptosis-like cell death of human breast cancer cell line MCF-7 induced by buprenorphine hydrochloride. Life Sci 75: 287-299, 2004.
38. Lee ATC and Azimahtol Hawariah LP: Styrylpyrone derivative induces apoptosis through the up-regulation of Bax in the human breast cancer cell line MCF-7. J Biochem Mol Biol 36: 269-274, 2003.
39. Cheah YH and Azimahtol Hawariah LP: Xanthorrhizol exhibits antiproliferative activity on MCF-7 breast cancer cells via apoptosis induction. Anticancer Res 26: 4527-4534, 2006.
40. Talanian RV, Quinlan C, Trautz S, Hackett MC, Mankovich JA, Banach D, Ghayur T, Brady KD and Wong WW: Substrate specificities of caspase family proteases. J Biol Chem 272: 9677-9682, 1997.
41. Kojima H, Endo K, Moriyama H, Tanaka Y, Alnemri ES, Slapak CA, Teicher B, Kufe D and Datta R: Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem 273: 16647-16650, 1998.
42. Lee ATC, Azimahtol Hawariah LP and Tan AN: Styrylpyrone derivative (SPD) induces apoptosis in a caspase-7-dependent manner in the human breast cancer cell line MCF-7. Cancer Cell Int 3: 16-23, 2003.
43. Germain M, Affar EB, D'Amours D, Dixit VM, Salvesen GS and Poirier GG: Cleavage of automodified poly (ADP-ribose) polymerase during apoptosis. J Biol Chem 274: 28379-28384, 1999.
44. Tentori L, Portarena I and Graziani G: Potential clinical applications of poly (ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 45: 73-85, 2002.